Added to YB: 2025-09-09
Pitch date: 2025-07-23
ANEB [bearish]
Anebulo Pharmaceuticals, Inc.
+29.75%
current return
Author Info
No bio for this author
Company Info
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States.
Market Cap
$93.7M
Pitch Price
$3.26
Price Target
1.83 (-20%)
Dividend
N/A
EV/EBITDA
N/A
P/E
-10.13
EV/Sales
N/A
Sector
Pharmaceuticals
Category
special_situation
Anebulo Pharmaceuticals, Inc. - $ANEB
ANEB short: Reverse split to cash out small holders at $3.50 caused 20M share arb frenzy vs 19k daily avg. Est cost skyrocketed from $1.8M to potentially $8.75M+ vs $13.3M cash. Similar to Parker Drilling fiasco. Upside to $1.83 if deal cancelled due to prohibitive costs.
Read full article (3 min)